Meilleure Health International Industry Group Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Meilleure Health International Industry Group.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Trade Distributors	6.5%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Meilleure Health International Industry Group's (HKG:2327) Shareholders May Want To Dig Deeper Than Statutory Profit

Oct 04

Earnings Not Telling The Story For Meilleure Health International Industry Group Limited (HKG:2327) After Shares Rise 34%

Sep 05

Meilleure Health International Industry Group (HKG:2327) Has A Somewhat Strained Balance Sheet

Aug 30

Meilleure Health International Industry Group Limited's (HKG:2327) 31% Share Price Plunge Could Signal Some Risk

Jul 19

Meilleure Health International Industry Group (HKG:2327) Will Be Hoping To Turn Its Returns On Capital Around

Jun 17

Optimistic Investors Push Meilleure Health International Industry Group Limited (HKG:2327) Shares Up 32% But Growth Is Lacking

May 03

Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality

Apr 04

Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%

Feb 28

Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)

Jan 23

Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down

Aug 17

Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)

Oct 18

Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?

Sep 06

Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist

Jul 12

Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?

Sep 09

Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue

May 15

Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly

Apr 18

Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?

Jan 29

Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay

Dec 08

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Meilleure Health International Industry Group no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

SEHK:2327 - Estimaciones futuras de los analistas y datos financieros pasados (HKD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2024	84	31	56	56	N/A
3/31/2024	107	36	-41	-40	N/A
12/31/2023	129	41	-137	-136	N/A
9/30/2023	130	33	-123	-122	N/A
6/30/2023	130	25	-109	-108	N/A
3/31/2023	125	22	-33	-32	N/A
12/31/2022	120	18	42	43	N/A
9/30/2022	148	23	42	46	N/A
6/30/2022	177	28	43	49	N/A
3/31/2022	215	44	-24	-17	N/A
12/31/2021	253	60	-90	-83	N/A
9/30/2021	263	72	-27	-24	N/A
6/30/2021	273	84	35	36	N/A
3/31/2021	269	84	53	53	N/A
12/31/2020	265	83	70	71	N/A
9/30/2020	262	32	11	11	N/A
6/30/2020	259	-19	-49	-48	N/A
3/31/2020	247	-19	-12	-12	N/A
12/31/2019	235	-20	25	25	N/A
9/30/2019	221	31	74	74	N/A
6/30/2019	208	83	123	123	N/A
3/31/2019	219	82	70	70	N/A
12/31/2018	231	81	18	18	N/A
9/30/2018	181	81	-40	-38	N/A
6/30/2018	132	81	-98	-94	N/A
3/31/2018	101	81	N/A	-79	N/A
12/31/2017	69	80	N/A	-63	N/A
9/30/2017	83	60	N/A	-177	N/A
6/30/2017	97	40	N/A	-291	N/A
3/31/2017	82	37	N/A	-276	N/A
12/31/2016	67	34	N/A	-261	N/A
12/31/2015	76	10	N/A	0	N/A
9/30/2015	17	-1	N/A	-45	N/A
6/30/2015	13	0	N/A	-21	N/A
3/31/2015	9	2	N/A	3	N/A
12/31/2014	16	1	N/A	29	N/A
9/30/2014	22	0	N/A	54	N/A
6/30/2014	29	44	N/A	63	N/A
3/31/2014	35	89	N/A	72	N/A
12/31/2013	34	87	N/A	47	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de 2327 es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de 2327 crezcan más rápidamente que el mercado Hong Kong

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de 2327 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de 2327 crezcan más rápidamente que el mercado de Hong Kong.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de 2327 crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de 2327 se prevé que sea elevada dentro de 3 años.

Meilleure Health International Industry Group Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

Recent updates

Executive Co-Chairman of the Board recently bought HK$1.2m worth of stock

Executive Co-Chairman of the Board recently bought HK$245k worth of stock

Meilleure Health International Industry Group's (HKG:2327) Shareholders May Want To Dig Deeper Than Statutory Profit

First half 2024 earnings released: EPS: HK$0.002 (vs HK$0.004 in 1H 2023)

Now 21% undervalued

Executive Co-Chairman of the Board recently bought HK$432k worth of stock

New major risk - Revenue and earnings growth

Earnings Not Telling The Story For Meilleure Health International Industry Group Limited (HKG:2327) After Shares Rise 34%

Executive Co-Chairman of the Board recently bought HK$715k worth of stock

Meilleure Health International Industry Group (HKG:2327) Has A Somewhat Strained Balance Sheet

New minor risk - Share price stability

Meilleure Health International Industry Group Limited to Report First Half, 2024 Results on Aug 31, 2024

Meilleure Health International Industry Group Limited's (HKG:2327) 31% Share Price Plunge Could Signal Some Risk

Executive Co-Chairman of the Board recently bought HK$592k worth of stock

Meilleure Health International Industry Group (HKG:2327) Will Be Hoping To Turn Its Returns On Capital Around

Executive Co-Chairman of the Board recently bought HK$485k worth of stock

Optimistic Investors Push Meilleure Health International Industry Group Limited (HKG:2327) Shares Up 32% But Growth Is Lacking

Executive Co-Chairman of the Board recently bought HK$119k worth of stock

Meilleure Health International Industry Group Limited Announces Board and Committees Changes

Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality

Full year 2023 earnings released: EPS: HK$0.01 (vs HK$0.004 in FY 2022)

Dividend reduced to HK$0.004

Meilleure Health International Industry Group Limited, Annual General Meeting, Jun 27, 2024

Meilleure Health International Industry Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 20 August 2024

Meilleure Health International Industry Group Limited to Report Fiscal Year 2023 Final Results on Mar 28, 2024

Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%

Now 31% undervalued after recent price drop

Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)

Executive Co-Chairman of the Board recently bought HK$135k worth of stock

Executive Co-Chairman of the Board recently bought HK$133k worth of stock

Executive Co-Chairman of the Board recently bought HK$251k worth of stock

First half 2023 earnings released: EPS: HK$0.004 (vs HK$0.003 in 1H 2022)

New minor risk - Earnings quality

Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down

Meilleure Health International Industry Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

Meilleure Health International Industry Group Limited to Report First Half, 2023 Results on Aug 31, 2023

Upcoming dividend of HK$0.016 per share at 5.4% yield

Executive Co-Chairman of the Board recently bought HK$274k worth of stock

Meilleure Health International Industry Group Limited Approves Final Dividend

Executive Co-Chairman of the Board recently bought HK$153k worth of stock

Executive Co-Chairman of the Board recently bought HK$145k worth of stock

Full year 2022 earnings released: EPS: HK$0.004 (vs HK$0.014 in FY 2021)

Executive Co-Chairman of the Board recently bought HK$1.1m worth of stock

Executive Co-Chairman of the Board recently bought HK$272k worth of stock

Executive Co-Chairman of the Board recently bought HK$325k worth of stock

Less than half of directors are independent

Executive Co-Chairman of the Board recently bought HK$169k worth of stock

Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?

First half 2022 earnings released: EPS: HK$0.003 (vs HK$0.01 in 1H 2021)

Meilleure Health International Industry Group Limited to Report First Half, 2022 Results on Aug 26, 2022

Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist

Meilleure Health International Industry Group Limited, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Executive Co-Chairman of the Board recently bought HK$305k worth of stock

Full year 2021 earnings released: EPS: HK$0.014 (vs HK$0.02 in FY 2020)

Executive Co-Chairman of the Board recently bought HK$1.1m worth of stock

Independent Non-Executive Director recently sold HK$142k worth of stock

Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?

First half 2021 earnings released: EPS HK$0.01 (vs HK$0.01 in 1H 2020)

Executive Co-Chairman of the Board recently bought HK$1.7m worth of stock

Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue

Full year 2020 earnings released: EPS HK$0.02 (vs HK$0.005 loss in FY 2019)

Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly

Executive Co-Chairman of the Board recently bought HK$441k worth of stock

Full year 2020 earnings released: EPS HK$0.02 (vs HK$0.005 loss in FY 2019)

Meilleure Health International Industry Group Limited to Report Fiscal Year 2020 Results on Mar 19, 2021

New 90-day high: HK$0.69

Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?

New 90-day high: HK$0.57

Executive Co-Chairman of the Board recently bought HK$1.5m worth of stock

Executive Co-Chairman of the Board recently bought HK$1.4m worth of stock